Healthcare

Cholic Acid Market

By Segment, By Region, And Segment Forecasts, 2016 – 2024

Vertical: HealthcareBase Year: 201811 Sections

Executive Summary

Cholic Acid Market — Snapshot

  • Market Size (2016)

    2016

    $49.74B

  • Projected (2024)

    2024

    $92.41B

  • CAGR (2016–2024)

    8.0%

    8.0%
  • Key Players

    113+

This report covers Cholic Acid Market with forecasts from 2016 to 2024. 113 key companies are profiled.

Key Insight

The Cholic Acid Market market is projected to grow at a CAGR of 8.0% from 2016 to 2024.

Market Performance Trend

Historical performance and future projections (2020–2030, USD Billion)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Scope & Coverage

What this report covers

  • Geographic Coverage: This analysis covers 4 regions: Asia Pacific, Europe, Middle East and Africa, Americas.
  • Market Segmentation: The market is analyzed across key segments with forecasts from 2016 to 2024.
  • Competitive Landscape: 113 leading companies are profiled, covering market positioning, strategies, and recent developments.

Market Size (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Overview

Cholic Acid Market — Growth Trajectory

Cholic acid is a primary bile acid synthesized by the liver from cholesterol. The role of bile acids is to emulsify (breakdown into small particles) fats and thus promote the process of digestion. Cholic acid is primarily used as an intermediate for the production of ursodeoxycholic acid (UDCA), which is an active pharmaceutical ingredient (API) used for various indications like the dissolution of gall stones and treating and preventing liver diseases.

Market Size Trend (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Dimensions

How this market is segmented

  • Segmentation The Cholic Acid Market market is analyzed across multiple dimensions with regional breakdowns.

Geographic Analysis

Regional market breakdown

  • Asia Pacific Asia Pacific market size reached $14.98B in 2016 and is projected to reach $28.50B by 2024, growing at a CAGR of 8.4%.
  • Europe Europe market size reached $19.88B in 2016 and is projected to reach $35.14B by 2024, growing at a CAGR of 7.4%.
  • Middle East and Africa Middle East and Africa market size reached $1.17B in 2016 and is projected to reach $2.19B by 2024, growing at a CAGR of 8.1%.
  • Americas Americas market size reached $13.72B in 2016 and is projected to reach $26.58B by 2024, growing at a CAGR of 8.6%.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Research Methodology

Cholic Acid Market — How We Researched This Market

This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.

  • Base Year

    2018

  • Historical Period

    2016 – 2018

  • Forecast Period

    2018 – 2024

  • Primary Interviews

    150+

Research Process

Historical data (2016–2018) and forecast period (2018–2024)

1

Problem Definition

  • Market scoping
  • Objective setting
  • Framework design
2

Secondary Research

  • Literature review
  • Data mining
  • Trend analysis
3

Primary Research

  • Expert interviews
  • Field visits
  • Surveys
4

Data Analysis

  • Quantitative modeling
  • Statistical testing
  • Validation
5

Insights & Reporting

  • Synthesis
  • Recommendations
  • Visualization

Research Depth

Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.

Historical vs. Forecast Data

Historical (observed)
Forecast (modelled)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Competitive Landscape & Porter's Five Forces

Cholic Acid Market — Competitive Analysis

Threat of New Entrants

The threat of new entrants is medium in the global cholic acid market. In Porter’s Five Forces Analysis, the ‘Threat of New Entrants’ refers to the threat that new competitors pose to existing competitors in an industry. A profitable industry will attract more competitors looking to achieve profits. As the number of entrants increases, the profitability of the present players in the industry subsequently decreases. The global cholic acid market has a medium threat of new entrants, threatening the existing players.

Bargaining Power of Suppliers

Bargaining power of suppliers in the global cholic acid market is medium. The bargaining power of suppliers estimates how easy it is for the suppliers to influence the prices of the final products made by innovators. Businesses must obtain the necessary resources that they need from the resource suppliers to carry out their activities.

In the global cholic acid industry, the number of suppliers is comparatively less than the number of firms operating in the sector, and only a few of them have a large hold on the cholic acid market. The recessionary pressures have reduced the price of many components and raw materials due to downward demand trends. Moreover, the switching cost of these suppliers is also medium as the suppliers tend to enter long-term associations with the manufacturers.

1.1.3 Threat of Substitutes

The threat of substitutes in the global cholic acid market is medium to low. The substitute to the cholic acid can only be in the form of large molecules. Buyer propensity to substitute is low due to the lesser availability of substitutes in this market. In addition, the high degree of switching cost minimizes the threat of substitutes.

Bargaining Power of Buyers

The bargaining power of the buyer is considered to have a low impact on the industry. The bargaining power of the buyers evaluates how easy it is for the buyers to affect the price of pharmaceutical products. There is a low number of players with capabilities to manufacture high-end drugs.

Also, the high differential advantage of the cholic acid market coupled with low or poor existing substitutes for high tech products makes the position of the manufacturers strong.

Intensity of Rivalry

The degree of competition in the global cholic acid market is high. The moderate degree of product differentiation among existing players increases the intensity of rivalry in the market. The intensity of competitive rivalry evaluates the capability and the level of rivalry among competitors in the market. It also refers to the extent to which firms within an industry put pressure on one another and limit each other’s profit potential. Rivalry among industry players can affect industry profits through downward pressure on prices, increased innovation, increased advertising, and increased service/product improvements, among others.

Quantitative Analysis

Regional Breakdown

Regional market breakdown for Cholic Acid Market.

Regional Market Size (USD Mn)

Market estimates by geography (2024)

USD Mn

InsightEurope leads with $35.14B by 2024, while Americas is projected to grow fastest at a 8.6% CAGR.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Regional Market Data

REGION201620182024CAGRSHARE
Asia Pacific$14.98B$20.78B$28.50B8.4%31%
Europe$19.88B$26.59B$35.14B7.4%38%
Middle East and Africa$1.17B$1.61B$2.19B8.1%2%
Americas$13.72B$19.20B$26.58B8.6%29%
Total$49.74B$68.18B$92.41B8.0%100%

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans
Empower your Business
with Insights

Save over 20% on
Annual Subscription

See plans for professionals or small and medium businesses.

Wantstats analytics dashboard

Analytics

Cholic Acid Market — Key Findings

Analytical insights on Cholic Acid Market covering market dynamics, competitive landscape, and strategic outlook.

Key Analytical Findings

The Cholic Acid Market market is projected to reach $92.41B by 2024, growing at 8.0% CAGR.

Market Dynamics

Gallstones are deposits of cholesterol and other digestive fluids that form in the gallbladder. Cholic acid is used as an active pharmaceutical ingredient in manufacturing medications for dissolution of gallstones. Apart from treating gallstones, cholic acid is also used in treating bile acid synthesis disorders and Zellweger Spectrum Disorders.

Market Drivers

According to the American Cancer Society, gallstones are one of the major factors contributing to gallbladder cancer. The cases of gallbladder cancer diagnosed are increasing globally. For instance, according to a study by the World Cancer Research Fund (WCRF) International, around 2,20,000 new cases of gallbladder cancer were diagnosed globally in the year 2018.

This increase in the cases of gallbladder cancer reflects the probable increase in the increased prevalence of one of its factors, bile stones. Owing to this increase, the demand for cholic acid, which is used as an active pharmaceutical ingredient (API), is expected to increase and thus boost the global cholic acid market growth.

Market Opportunities

The European region is leading the manufacturing of cholic acid globally followed by the Americas and Asia-Pacific. The drug manufacturers in the Middle Eastern and African region mainly rely on import for meeting their requirement of cholic acid. Around 80% of the cholic acid is manufactured in other regions of the world, and only 20% is manufactured in the Middle East and Africa. This provides an opportunity for manufacturers to establish new manufacturing facilities for cholic acid.

Market Restraints

The exporters of cholic acid are abiding by the good manufacturing practice (GMP) in the European region, whereas the FDA is regulating the quality assurance in the US and other regions. The regulatory compliance is considered to be the primary hurdle challenging the cholic acid (API) market at every point.

Besides, the Indian cholic acid manufacturers are investing to comply with the US FDA regulations for obtaining contracts from the US-based companies. They are also filing the drug master file (DMF) applications in the US. Thus, it has been observed that Indian cholic acid manufacturers are strengthening their presence in the global cholic acid market. Although these regulations are serving to improve and maintain the quality of drugs, they are also curbing the growth of the cholic acid (API) manufacturing market, especially in developing regions of Asia-Pacific.

Strategic Outlook and Future Directions

Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.

Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.

Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.

Companies

Key companies profiled in Cholic Acid Market

Profiles of 113 companies operating in the Cholic Acid Market market, including revenue, employee count, and market positioning where available.

Showing 113 of 113 companies

Zhejiang Y

Zhejiang Yongning Pharmaceutical

Healthcare

Company Headquarters: Taizhou, Zhejiang Founded: 1974 Company Working: Zhejiang Yongning Pharmaceutical is a pharmaceutical company that is engaged in manufacturing and marketing of a wide range of innovative medicines and pharmaceutical APIs in China. It is one of the national high-tech companies in the Zhejiang province. It develops and sells antibiotic drugs, respiratory drugs, cardiovascular drugs, vitamin tablets, health care drugs, and other related products.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded1973
Taizhou, Zhejiang
Showa Denk

Showa Denko KK

Healthcare

Company Headquarters: Tokyo, Japan Founded: 1939 Workforce: ~10,476 Company Working: Showa Denko KK is a chemical company that engages in the manufacturing and marketing of a wide range of petrochemicals, chemicals, electronics, inorganic chemicals, aluminum, and other products. The company, along with its affiliates and subsidiaries, operates in North America, Europe, and Asia. It provides products and services that are useful and exceed customer expectation.

Revenue$6.2B
Employees10,476
Market CapN/A
Founded1938
Tokyo, Japan
PharmaZell

PharmaZell GmbH

Healthcare

Company Headquarters: Germany Founded: 1947 Workforce: ~800 Company Working: PharmaZell GmbH develops and manufactures APIs for pharmaceutical purposes. It provides services for the development of formulations and other pharmaceutical intermediates and produces amino acids. The company markets its products worldwide.

RevenueN/A
Employees800
Market CapN/A
Founded1946
Germany
Panjin Hen

Panjin Hengchanglong Pharmaceutical

Healthcare

Company Headquarters: China Founded: 1984 Workforce: ~260 Company Working: Panjin Hengchanglong Pharmaceutical is located in China. It offers 25 major pharmaceutical products and more than 100 kinds of traditional Chinese medicinal foods. The company is primarily involved in manufacturing tablets; hard capsules; pills such as water-honeyed pills and concentrated pills; APIs; tea-containing products; and herbal tea.

RevenueN/A
Employees260
Market CapN/A
Founded1983
China
New Zealan

New Zealand Pharmaceuticals Limited

Healthcare

Company Headquarters: Palmerston North, New Zealand Founded: 1971 Workforce: ~250 Company Working: New Zealand Pharmaceuticals Limited, manufactures pharmaceutical ingredients and diagnostic products for pharmaceutical and biotechnology companies. The company extracts and purifies biochemicals from the by-products of the New Zealand meat processing industry. It is one of the major manufacturers and suppliers of pharmaceutical products in the market. It also manufactures pharmaceutical ingredients, pharmaceutical intermediates, microbiological media, fermentation ingredients, dietary supplements, and cosmetic ingredients.

RevenueN/A
Employees250
Market CapN/A
Founded1970
Palmerston North, New Zealand
Kinsy SL

Kinsy SL

Healthcare

Company Headquarters: Alhama de Murcia, Murcia, Spain Founded: 1991 Workforce: ~200 Company Working: Kinsy SL is an independent chemical company headquartered in Spain. The company has a strong emphasis on the development and manufacturing of key APIs under the CGMP guidelines and manufacturing fine chemicals. The company’s primary focus is the development and synthesis of fine chemicals and pharmaceutical intermediates.

RevenueN/A
Employees200
Market CapN/A
Founded1990
Alhama de Murcia, Murcia, Spain
Page 1 of 19
Go to page

About the Author

Healthcare Research Team

Healthcare

Our healthcare desk at Wantstats is staffed by a mix of clinical-market analysts and a senior researcher who track drug approvals, device launches, and provider economics as they happen — not just at reporting time. Every figure in this report is checked against primary interviews, regulatory filings, and our own proprietary datasets before it goes to print.

Powering the world's best teams.
From next-gen startups to established enterprises.

Google logo
Amazon logo
Microsoft logo
Intel logo
Neste logo
McKinsey & Company logo
Deloitte logo
Accenture logo
Oracle logo
PWC logo
EY logo
Honeywell logo

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Cholic Acid Market

Starting from
$4,950